Status:

UNKNOWN

Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use Disorders

Lead Sponsor:

National Cheng-Kung University Hospital

Collaborating Sponsors:

Ministry of Science and Technology, Taiwan

Conditions:

Transcranial Magnetic Stimulation

Heroin Dependence

Eligibility:

All Genders

20-65 years

Phase:

NA

Brief Summary

Opioid use disorder (OUD) is prevalent and causes substantial health and social burdens. Although evidence have showed the effectiveness of opioid agonist maintenance therapy in OUD, high drop-out rat...

Eligibility Criteria

Inclusion

  • Signed informed consent by patient or legal representative.
  • Male or female patient aged ≧20 and ≦65 years.
  • A diagnosis of OUD according to DSM criteria made by a specialist in psychiatry.
  • Patient or a reliable caregiver can be expected to ensure acceptable compliance and visit attendance for the duration of the study.

Exclusion

  • Women of childbearing potential, not using adequate contraception as per investigator judgment or not willing to comply with contraception for the duration of the study.
  • Females who are pregnant or lactation.
  • Current evidence of an uncontrolled and/or clinically significant medical condition, e.g.,cardiac, hepatic and renal failure that would compromise patient safety or preclude study participation.
  • History of seizure or epilepsy.
  • History of neurological diseases or traumatic brain injury.
  • Suicidal attempts or risks during screen or study period.
  • Presence of devices, e.g. pace-makers, cochlear prosthesis, neuro-stimulators, magnetic cochlear prosthesis, intraocular metallic fragments.
  • Patient has received electroconvulsive therapy (ECT) within 4 weeks prior to the first intervention of the double-blinded treatment.

Key Trial Info

Start Date :

August 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03229642

Start Date

August 1 2017

End Date

December 31 2022

Last Update

September 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Cheng Kung University Hospital

Tainan, Taiwan

Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use Disorders | DecenTrialz